riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
sequidot transdermalni flaster
novartis hrvatska d.o.o., radnička cesta 37b, zagreb - estradiolum, norethisteronum - transdermalni flaster - 50/250 mikrograma/24 sata - urbroj: faza i: svaki flaster sadrži estradiol hemihidrat što odgovara 0,78 mg estradiola u flasteru površine 5 cm2, koji otpušta nominalnih 50 mikrograma estradiola u 24 sata; faza ii: svaki flaster sadrži estradiol hemihidrat što odgovara 0,51 mg estradiola i 4,80 mg noretisteronacetata u flasteru površine 16 cm2, koji otpušta 50 mikrograma estradiola i 250 mikrograma noretisteronacetata u 24 sata
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningitis, meningokokal - cjepiva - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.
brieka 100 mg tvrde kapsule
actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 100 mg - urbroj: svaka tvrda kapsula sadrži 100 mg pregabalina
brieka 150 mg tvrde kapsule
actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 150 mg - urbroj: svaka tvrda kapsula sadrži 150 mg pregabalina
brieka 200 mg tvrde kapsule
actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 200 mg - urbroj: svaka tvrda kapsula sadrži 200 mg pregabalina
brieka 225 mg tvrde kapsule
actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 225 mg - urbroj: svaka tvrda kapsula sadrži 225 mg pregabalina
brieka 25 mg tvrde kapsule
actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 25 mg - urbroj: svaka tvrda kapsula sadrži 25 mg pregabalina